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Abstract
Streptococcus pneumoniae globally kills more children than any other infectious disease
every year. A prerequisite for pneumococcal disease and transmission is colonization of the
nasopharynx. While the introduction of pneumococcal conjugate vaccines has reduced the
burden of pneumococcal disease, understanding the impact of vaccination on nasopharyn-
geal colonization has been hampered by the lack of sensitive quantitative methods for the
detection of>90 known S. pneumoniae serotypes. In this work, we developed 27 new quan-
titative (q)PCR reactions and optimized 26 for a total of 53 qPCR reactions targeting pneu-
mococcal serotypes or serogroups, including all vaccine types. Reactions proved to be
target-specific with a limit of detection of 2 genome equivalents per reaction. Given the num-
ber of probes required for these assays and their unknown shelf-life, the stability of cryopre-
served reagents was evaluated. Our studies demonstrate that two-year cryopreserved
probes had similar limit of detection as freshly-diluted probes. Moreover, efficiency and limit
of detection of 1-month cryopreserved, ready-to-use, qPCR reaction mixtures were similar
to those of freshly prepared mixtures. Using these reactions, our proof-of-concept studies
utilizing nasopharyngeal samples (N=30) collected from young children detected samples
containing2 serotypes/serogroups. Samples colonized by multiple serotypes/serogroups
always had a serotype that contributes at least 50% of the pneumococcal load. In addition,
a molecular approach called S6-q(PCR)2 was developed and proven to individually detect
and quantify epidemiologically-important serogroup 6 strains including 6A, 6B, 6C and 6D.
This technology will be useful for epidemiological studies, diagnostic platforms and to study
the pneumobiome.
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Introduction
Streptococcus pneumoniae (the pneumococcus) is a major human pathogen that causes dis-
eases, such as otitis media, pneumonia, septicemia and meningitis in children, the elderly and
immune compromised patients [1–3]. There are more than 90 pneumococcal capsular types
(serotypes) although a subset of serotypes are responsible for most cases of pneumococcal dis-
ease (PD) [4, 5]. Globally each year, the pneumococcus causes 15 million cases of serious dis-
ease, which lead to approximately 1 million deaths in children [5–7]. Vaccination with
pneumococcal conjugate vaccines (PCVs), the basis for which is induction of a protective anti-
body response against the bacterial polysaccharide capsule, has dramatically reduced the global
burden of PD [4, 8]. Licensed conjugated vaccines in the USA previously contained seven sero-
types (4, 6B, 9V, 14, 18C, 19F, 23F), but since 2010 have contained 13 (PCV7 plus 1, 3, 5, 6A,
7F and 19A) of the*94 known pneumococcal serotypes.
A prerequisite for PD is colonization of the human nasopharynx and persistence in this
niche, known as carriage. Pneumococcal carriage commonly occurs in early childhood [9, 10].
Before PCVs were introduced, the most prevalent serotypes implicated in PD and carried in
the nasopharynx belonged to vaccine types [4, 8]. In the post-PCV era, studies have consistent-
ly reported that carriage of vaccine types is decreasing whereas non-vaccine types are now in-
creasingly detected in nasopharyngeal (NP) samples, a phenomenon called serotype
replacement [4, 9, 11].
For nearly 50 years, studies of pneumococcal carriage have been based on bacterial culture
[12, 13]. Culture methods isolate one or more colonies from NP samples, for which the sero-
type is identified using serotype-specific antibodies, known as Quellung reaction or capsular
swelling reaction [14, 15]. The serotype can be alternatively investigated by a multiplex PCR
approach [16, 17].
Multiple carriage of pneumococcal strains has been investigated with modified culture
methods including conventional Quellung typing of at least five colonies [18], or latex aggluti-
nation of a sweep of colonies from a plate culture [19, 20]. Other methods isolate DNA directly
from the NP sample, or after an additional enrichment step, and utilize different platforms
such as multiplex PCR approaches [21–23], a microarray platform [19] or a MassTag PCR
assay [24].
Recently, a very high prevalence of multiple pneumococcal carriage was published by Turn-
er et al., by using both a sweep-latex agglutination method and microarray studies to demon-
strate that 43% or 48.8%, respectively, of NP swabs from Thai children carried more than one
pneumococcal serotype [19]. A similar prevalence of multiple serotype carriage (*40%) was
observed recently in Spain utilizing a combination of Quellung reactions and latex serotyping
along with multiplex PCR reactions [23]. Limitations of these methods is that they are not
quantitative although the microarray provides relative proportions of each serotype present in
a sample and may be quantitative when used together with a lytA quantitiatve PCR (qPCR)
[19, 25].
Two different groups have published a series of real-time PCR reactions for the detection of
more than 20 pneumococcal serotypes in single-plex reactions [22, 26] or a multiplex reactions
format [27]. Using real-time PCR, Azzari et al. detected multiple carriage in*60% of NP sam-
ples collected from children in Italy [22]. A multiplex real-time PCR approach developed by
Pimenta et al. (2013) was shown to be specific for the target pneumococcal serotypes or ser-
ogroups [27].
We have developed in this work protocols to optimize and validate quantitative real-time
PCR assays for pneumococcal serotyping and have developed new qPCR assays that, together
with published sequences, allow for the detection and for the determination of the bacterial
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load of 72 pneumococcal serotypes/serogroups. Given the quantitative nature of these single-
plex assays, we hereafter referred to these as qPCR to differentiate quantitative assays from
highly-sensitive, qualitative, real time reactions [22, 27]. As a proof-of-concept, we tested 30
pneumococcal-positive NP samples and identified at least one serotype in all tested NP sam-
ples. Half of those samples contained more than one serotype, and we identified up to 5 differ-
ent serotypes in a single sample. These quantitative assays identified serotypes for whom the
serotype-specific proportion was as little as 0.01% of the total pneumococcal load, i.e., as a pro-
portion of all combined serotype loads.
Material and Methods
Nasopharyngeal samples
NP samples (n = 30) were previously collected from children aged 24 months in Papua New
Guinea (n = 14), South Africa (n = 6), Bangladesh (n = 4), Fiji (n = 2), Kenya (n = 2) and The
Gambia (n = 2) as part of the PneuCarriage project [28]. Samples were collected and stored at
-80°C in skim-milk-tryptone-glucose-glycerin (STGG) transport medium [29] according to
WHO guidelines [14, 30]. Samples underwent one freeze-thaw for aliquoting purposes, and
60 μl aliquots were shipped on dry ice and stored at -80°C prior to testing by qPCR.
Bacterial strains utilized in this study
S. pneumoniae serotypes utilized in this study were obtained either from the Statens Serum In-
stitute (SSI) or had been previously typed by the Quellung reaction at the Centers for Disease
Control and Prevention (CDC) and kindly provided by Dr. Lesley McGee and Dr. Bernard
Beall, or isolated in our laboratories and Quellung typed. Pneumococcal strains include the fol-
lowing serotypes: 1, 3, 4, 5, 6A, 6B, 6C, 6D, 7A, 7B, 7C, 7F, 8, 9A, 9L, 9N, 9V, 10A, 10B, 11A,
11D, 11F, 12A, 12B, 12F, 13, 14, 15A, 15B, 15C, 15F, 16F, 18B, 18C, 19A, 19B, 19F, 19“F” (atyp-
ical), 20, 21, 22A, 22F, 23A, 23B, 23F, 24A, 25A, 25F, 27, 29, 31, 33A, 33B, 33D, 33F, 34, 35A,
35B, 35C, 35F, 36, 38, 39, 40, 41A, 41F, 42, 43, 45, 46, 47A, 47F.
Streptococci naturally found in the nasopharynx and other anatomic sites were also utilized
to validate S. pneumoniae serotype-specific qPCR assays and included: S. infantis, S. oralis, S.
anguinosus, S. intermedius, S. sobrinus, S. pseudopneumoniae, S.mitis, S. parasanguinis, S. aus-
tralis, S.mutans, S. peroris, S. oligofermentans, S. intestinalis, S. vestibularis, S. cristatus, S. sali-
varius, S. gordonii, S. sanguinis, S. sinensis and Dolosigranulum pigrum [31, 32]. Reference,
genome-sequenced, TIGR4 (GenBank accession # Z_AAGY00000000) [33] was utilized to pre-
pare DNA standards for the lytA qPCR assay [25].
DNA extraction from reference strains and nasopharyngeal samples
DNA from bacterial cultures and nasopharyngeal samples was purified using the QIAamp
DNAmini kit (Qiagen) as detailed elsewhere [21, 31, 34]. DNA from bacterial cultures, or
from NP samples, was eluted in a final volume of 100 μl. Quality and quantification of DNA
preps obtained from bacterial cultures was further evaluated using the Nanodrop system
(Nanodrop Technologies, Wilmington, DE).
Preparations of DNA standards for quantitative (qPCR) assays
Purified DNA from S. pneumoniae serotype control strains was adjusted to a concentration of
1 ng/μl in TE buffer (10mM Tris-HCl, 1mM EDTA, pH8.0) and immediately stored at -80°C
until use. Standards for quantification purposes were prepared within an hour before reactions
were performed by serial dilution of a 1 ng/μl aliquot in TE buffer to a final concentration of
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100 pg/μl, 10 pg/μl, 1 pg/μl, 100 fg/μl, 50 fg/μl, or 5 fg/μl of pneumococcal DNA. Given the
2.1608 Mb genome size of TIGR4 [33], these standards corresponded to 4.29x105, 4.29x104,
4.29x103, 4.29x102, 4.29x101, 2.14x101, or 2.14 genome equivalents, respectively. Standards
prepared using this protocol obtained an efficiency>90% throughout the study (not shown).
qPCR studies
The total density of S. pneumoniae, reported as CFU/ml, was determined by a qPCR assay tar-
geting the lytA gene, essentially as described previously [25]. Reactions were performed utiliz-
ing Platinum Quantitative PCR Super Mix-UDG (life technology, USA) and 2.5 μl of pure
DNA as template. Final concentration and sequences of the following primer and probe were
utilized: forward primer (5’-ACGCAATCTAGCAGATGAAGCA-3’; 100 nM), reverse primer
(5’-TCGTGCGTTTTAATTCCAGCT-3’; 100 nM), and probe (5’-FAM-TGCCGAAAA-
CGCTTGATACAGGGAG-3-BHQ1; 100 nM). Details of cycling conditions were reported in
[25]. Serotype-specific reactions were performed in 10 μl reactions containing 1x SsoAdvanced
Universal Probes Supermix (Bio-Rad, Hercules, CA), serotype-specific primers and probe at a
concentration listed in Table 1 and S1 Table, and 1 μl of DNA as template. Serotype specific
qPCR reactions were conducted using: one cycle of 95°C for 2 min; 40 cycles of 95°C for 15 s
and 60°C for 30 s. To quantify the molecular bacterial load (CFU/ml), genomic DNA purified
from control stains was serially diluted to prepare standards as described earlier. These stan-
dards were run along with DNA from NP samples in a CFX96 real time PCR-detection system
(Bio-Rad, Hercules CA) and CFU/ml were calculated using the software Bio-Rad
CFX manager.
Development of qPCR assays to detect and quantify S. pneumoniae
serotypes
A new set of qPCR reactions (primer and probe sequences) was designed in silico utilizing se-
quences of the cps locus available in the GenBank (Table 1). We also included sequences of
atypical 19F strains, denoted as 19“F”. The cps loci of this variant was recently described having
88% homology with 19A cps sequences [35, 36]. To identify serotype-specific target sequences
for our qPCR assays, we aligned the cps locus of all available S. pneumoniae serotypes utilizing
NCBI-Basic Local Alignment Search Tool (NCBI-BLAST) and the DNASTAR Lasergene soft-
ware version 11.2.1 (DNASTAR Inc., Madison WI). Identified serotype-specific sequences
were further blasted against all organisms in the NCBI database to verify that there was not sig-
nificant in silico homology with other species. Primer and probe were designed utilizing the
software from Integrated DNA technologies (http://www.idtdna.com/site), or Primer3plus
(http://www.bioinformatics.nl/cgi-bin/primer3plus/primer3plus). Primer and probe sequences
were additionally blasted as above mentioned to further verify specificity for the target pneu-
mococcal serotype(s). Primers and probes were synthesized by Sigma-Aldrich Co.
High-throughput evaluation of specificity of qPCR assays
The specificity of our newly designed assays, and some previously published reactions [22, 26],
was evaluated against DNA (100 pg) purified from all S. pneumoniae serotypes and several na-
sopharyngeal streptococci. To set up a rapid and high-throughput screening we prepared two
DNA reference libraries, in a 96-well microtiter plate platform, containing either DNA from S.
pneumoniae serotypes or DNA from streptococci species. DNA concentrations were adjusted
to 40 pg/μl in 150 μl of TE buffer and then added to each well of a 96-well microtiter plate, and
which were cryopreserved at -80°C. We first tested specificity for S. pneumoniae serotypes as
follows: the library of pneumococcal DNA was thawed on ice and 2.5 μl (100 pg/reaction) were
Single-Plex Assays for Pneumococcal Serotyping
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Table 1. Primers and probes designed and validated in this study.
Serotype Sequence* Target
region
Accession
No.
Position Size
(bp)
Limit of
detection
(fg)
Concentration
(nM)
6CD Forward CAATCAGGCAGTTCTTTTCTCG wciNbeta EF538714 7319–7340 133 5 500
Reverse ACCTGACTCACCATCAATAACC 7430–7451 500
Probe AAATGGGAGGGCTTTGGATTGGC 7341–7363 200
7BC/40 Forward TCCAGATATAGTCATTCCCAATCAG wcxU CR931641 10720–10744 147 50 400
Reverse AAAGAAGGTAAATCCCATGATGAATT 10841–10866 400
Probe TGGTGGGTCAGTAATCGATAATGAGGGA 10798–10825 200
7C Forward AGTTTGAGCATAACGGAGCG wchF CR931642 7010–7029 132 5 200
Reverse GAGCTTCATCCTTATTTTCCTTAGC 7117–7141 200
Probe CTCGAGCTGGACCAATATTCGGAACAT 7046–7072 200
9LN Forward CGTGGAATTTTCTATACTGCAATAGG wzx CR931646 11762–11787 115 5 500
Reverse CTACTGCTACGATACCATATTCTACAG 11850–11876 500
Probe CAGCAATTCTTAGCCGGATTCTCTCACC 11823–11850 200
10A Forward AGAGGCCCTAAGAAAAGATTCG wcrD CR931649 10268–10289 137 5 400
Reverse CCCAGTCATCCCCATCAATAAC 10383–10404 400
Probe TGTTGAGCCATGACCTCCATTTTCCT 10315–10340 200
10B Forward AAATATGAGATTGGTAAGGAATATTCTGG wcrD CR931650 10237–10265 116 5 400
Reverse GTCTTTTCACTTAAACGAATTCCATTC 10326–10352 400
Probe AACGGATTCCAATGCACTCGGTAACT 10277–10302 200
11F Forward TGGTCCAGCTACTTTTATGGC wchK CR931657 7485–7505 93 5 400
Reverse TGATCATTCACATGCTCCCC 7558–7577 400
Probe ACTCCAATAGTTGTTCCGAGGCAAAAGA 7525–7552 200
12B Forward TTGGTTGCTGATCAAAAGGTC wzx CR931659 13259–13279 228 5 600
Reverse CATTTTTGGAAGTGGAGCTATC 13465–13486 600
Probe TCACTTTGATGATTTGGAAAGATTTT 13338–13363 400
13 Forward AGACTACCATTTTTTGATCAGTTAGATT wzy CR931661 13163–13190 136 5 500
Reverse CAGAAAACATATTTTGTTCATAAATCCATC 13269–13298 500
Probe AAGCAGCACTTCCAAGTCGTAATCTACC 13202–13229 300
19“F” Forward GTCCTTAGTTCTGGTTATTCGGG wzy FJ829071 364–386 106 5 400
Reverse GGATGAGGAACCGAATCGAAG 449–469 400
Probe CCAGTTATGAAGGTGAGCTAACAGTGCG 419–446 300
24A Forward CTTGGAGTTGCTAATTATGGGAAG wzx CR931686 15526–15549 120 5 300
Reverse ATCTCTTACACGTGCACACTC 15625–15645 300
Probe CTGCGGGTATTTTACGATATGCTGTGCG 15596–15623 200
25AF Forward ATACCAACTAGAATCAGCAGGAC wcyE CR931689 16881–16903 128 5 400
Reverse AAATGGAATATCTTTTGATAATTTACTCGC 16979–17008 400
Probe CCCGCTGGACTTACTGCAATACTCG 16949–16973 200
27 Forward AGCGATTTAGCGACTGATATCC whaK CR931691 7805–7826 79 50 400
Reverse TCTCAAAATCGATCTCGCGTG 7863–7883 400
Probe TGTGGAAGGCGTTTGAAGGTGACT 7839–7862 200
31 Forward GCAGAAGTTTTAAGTCACGGAC wzy CR931695 9303–9324 146 5 500
Reverse AGCATTACAGATGTCACTAAGGG 9426–9448 500
Probe CCCCCACGTAAAACCGCAAGG 9395–9415 200
33B Forward CCTGTTAGTGCACCTGTATTTAAC wciN CR931699 7069–7092 146 5 500
Reverse GCATTCAAAACTCCTTCATCTCC 7192–7214 500
Probe TCCTCGATTCGTTGTTCACGCCA 7123–7145 200
(Continued)
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transferred with a multi-channel pipette to a qPCR plate containing the reaction cocktail of the
serotype-specific qPCR assay to be tested. These real-time reactions were performed in a
CFX96 real time PCR-detection system (Bio-Rad, Hercules CA). A typical positive/specific re-
action showed a Ct value between 20–30. Once specificity for the target pneumococcal serotype
was confirmed, the library containing DNA purified from other streptococci was then utilized
as above mentioned to assure reactions did not cross-react with DNA from these
nasopharyngeal species.
Table 1. (Continued)
Serotype Sequence* Target
region
Accession
No.
Position Size
(bp)
Limit of
detection
(fg)
Concentration
(nM)
33D Forward CGTATAGTCTTGCGACATTTCA wciN CR931701 7325–7346 81 5 400
Reverse TTCCACATGCGTTACCTCAC 7386–7405 400
Probe TCAAAAAGACCTTGGCAAGAAAGT 7361–7384 200
34 Forward CGGTGGAGTAGGTCAAGATG wzy CR931703 8096–8115 144 5 300
Reverse GTCTGTTCTCCCCAATATACTGAG 8216–8239 300
Probe ACGGAGCGCCAATGTACTTGAATAGTT 8140–8166 200
35AC/42 Forward GCTTCCCCTTTAGACTATTCGG wcrK CR931704 11012–11033 108 5 400
Reverse AAATGAAATCAAAGTATCACGTATCGA 11093–11119 400
Probe TTCAAAATACCCAGGACACCCGTTCA 11062–11087 200
35F/47F Forward GTGGTCGTATATACTTGATGAATAAATCG wzy CR931707 7694–7722 145 5 400
Reverse ACATACAAATTATCAACATACAGATAGGTC 7809–7838 400
Probe TCCATTCAACTGGTCGTCCGAATAATCC 7741–7768 200
36 Forward CTTGTCTATTCAGCCCTTCTGG wzy CR931708 13287–13308 148 5 500
Reverse CGCGATTATATTGTAAATTGGGAACT 13409–13434 500
Probe TGCCCGCTACAATGAGATACGTTTTCAA 13341–13368 200
39 Forward CAAAAAAATGAACTAACTCAAATAGTAACG wcrG CR931711 12614–12643 143 5 300
Reverse ATACTGTAATTTTCTTGTTTATTTGCGG 12729–12756 300
Probe AAGTCAGGCGTATTCTTCACAAGGGAAA 12644–12671 200
41A Forward GCAAATAGATGTATCCCAGTTAACAC wciB CR931713 7130–7155 114 50 300
Reverse GGTAGCTCTTTTGGTTTAATGTCC 7220–7243 300
Probe CACGACCGAATAGTCTAGCTTCAAAGGG 7155–7182 200
41F Forward TTTTTGGGAGGAAGTGCTTTT wzx CR931714 14008–14028 134 5 500
Reverse AAAACCGCTTTCTCATGATTC 14121–14141 500
Probe TTTCTTCTGTGCTAACAGTGGAGA 14030–14053 200
43 Forward AGAGGCTACATCAAATAGTTGGC wzx CR931716 16435–16457 150 5 400
Reverse GAATCACACCGTAACTTCCAAAG 16562–16584 400
Probe TCCAATAGTACTCACCCCTACCGAGC 16471–16496 200
45 Forward TCTAGCTACTTGACTAAAATATTTGAACTG wzy CR931718 13743–13772 88 50 400
Reverse GACGAGTCGATTTCGCTGTAT 13810–13830 400
Probe TAGGGAGCGAGGTCACTAAAAGTCGT 13774–13799 200
46 Forward CGAAGTTTTTATATCTCTATTGGTTTG wzy CR931719 9232–9258 133 50 1000
Reverse TATCCCAGGAACTGGACGAA 9345–9364 1000
Probe TCATTCTTTCTTCAATTCCTTTCTGA 9319–9344 500
47AF Forward AGGAATTGGTAGAGAGTTTGTGG whaI CR931721 8235–8257 121 50 400
Reverse GAAAGTTGAACCATCATCCGTC 8334–8355 400
Probe CACTTGATGGAATGCCTGCTGCC 8271–8293 200
*Probes were labeled at 5’ with FAM (6-carboxyﬂuorescein) and at 3’ with BHQ1 (Black Hole Quencher-1).
doi:10.1371/journal.pone.0121064.t001
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Evaluation of long term storage of probes and pre-mixed qPCR reaction
cocktails at -20°C
To evaluate proper fluorescence activity of our FAM-labeled qPCR probes, once probes were
received in the lab they were solubilized with DNA grade water to a final concentration of
5 μM and utilized immediately, or cryopreserved at -20°C in 100 μl aliquots. Efficiency of
qPCR reactions of cryopreserved probes was evaluated at different time points using reaction-
specific standards.
Some qPCR reaction mixtures, including those for serotypes 9AV, 9LN, and lytA, were
also prepared cryopreserved at -20°C and efficiency of those reactions was evaluated at differ-
ent times for four months. Quantitative reactions were performed essentially as described
earlier.
PCR reactions to subtype serogroup 6 strains
These reactions were performed as previously described [37, 38] except that we utilized DNA
purified from NP samples. Briefly, DNA (2 μl) was used as template in 25 μl PCR reactions
containing 50 pmol/μl of each of the pair of primers listed below, 2.5 mmol/l of dNTP, 2.5 μl of
10xPCR buffer (Qiagen), 0.1 μl of Qiagen HotStar Taq polymerase, and molecular biology
grade water (Thermo). Reactions specifically target single nucleotide polymorphism within the
wciP gene and therefore the following primers will amplify a PCR product from: serotype 6A
and 6C, primers wciP584gS (5'-ATTTATATATAGAAAAACTGGCTCATGATAG-3') and,
wciPr (5'-GCGGAGATAATTTAAAATGATGACTAGTTG-3'), or a PCR product from sero-
type 6B and 6D with primers wciP584aS (5'-AAGATTATTTATATATAGAAAAACTGTCT-
CATGATAA-3') and wciPr. Cycling parameters were: one cycle at 95°C for 15 min, 35
cycles of 94°C for 30 s, 62°C for 1 min, and 72°C for 1 min; and a final extension of 72°C for
10 min. Products were run on 3% agarose gels, stained with SYBR Safe DNA gel stain (life tech-
nologies, Grand Island, NY) and visualized under a UV transilluminator (BioRad, Hercules
CA).
Results
Validation, optimization and limit of detection of qPCR assays for
detecting pneumococcal serotypes
A total of 27 new serotype/sergroup-specific qPCR assays were developed in this study includ-
ing 20 serotype-specific reactions and 7 reactions detecting serotypes within a specific ser-
ogroup (i.e, 6C and 6D) or two different serogroups. Bioinformatic studies and our high-
throughput validation system confirmed the specificity of the new assays for the target pneu-
mococcal serotype(s). They did not cross-react with DNA from nasopharyngeal streptococci
and only detected the pneumococcal serotypes listed. The concentration of primer and probe
of new qPCR assays (N = 27), and those of available sequences (N = 26), were further opti-
mized for their use in quantitative single-plex reactions and results reported in Table 1 and S1
Table. Together, this panel of newly developed and optimized qPCR assays detect and quantify
bacterial loads for most important pneumoccocal serotypes/serogroups. To investigate the
limit of detection and efficiency of our quantitative assays, serially diluted DNA was evaluated
at least three times using all qPCR reactions. Most reactions were able to detect as little as 5 fg
of S. pneumoniae DNA, the genome equivalent of*2 bacteria per reaction, with an efficiency
>90% (Table 1 and S1 Table). Quantitative reactions were not able to detect 1 genome equiva-
lent (*2.5 fg) even after 60 qPCR cycles (not shown).
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Cryogenic preservation of S. pneumoniae serotype-specific FAM-
labeled qPCR probes
A number of fluorescence-labeled probes would be required in order to detect and quantify by
qPCR most S. pneumoniae serotypes. Therefore, we evaluated during a 2-year period the limit
of detection and efficiency of 14 selected qPCR reactions whose probes were stored at -20°C
protected from light sources. At day 0, probes were diluted with molecular grade DNase-,
RNase-free water to a final 5 μM concentration and immediately utilized in qPCR reactions. At
the same time 100 μl aliquots were made and stored at -20°C until future testing.
An aliquot of 100 μl of a FAM-labeled probe (5 μM) is enough to run qPCR reactions in two
96-well plates, therefore aliquots were thawed/freeze only once or twice. S2 Table shows that ef-
ficiency of reactions containing probe 19BF or probe for serogroup 15 remained>93% after 2
years at -20°C. Most quantitative reactions detected the genome equivalent of 2 bacteria
throughout the trial period (S2 Table). Similar results were obtained with other 12 probes in-
cluding those probes for qPCR assays targeting vaccine serotypes 1, 4, 6ABCD, 9AV, 14 or 23F.
Therefore, cryogenic storage of these FAM-labeled probes for nearly two years did not affect
the limit of detection of qPCR assays.
Cryopreservation of premixed qPCR assays stored at -20°C
Preparing reaction mixtures for several qPCR assays might be time-consuming if different tar-
gets (i.e., for instance all these serotypes) are pursued. Quantitative molecular assays are also
highly sensitive whereby it is relatively easy to contaminate the reaction mixture with S. pneu-
moniae DNA if a dedicated room to assemble the reaction mixtures is not available. Therefore,
we evaluated the efficiency and limit of detection of selected qPCR assays that had been pre-
mixed and cryopreserved at -20°C for up to 2 months. We did not evaluate reaction mixtures
stored at -80°C since the qPCR master mix should be kept at -20°C.
The qPCR assay was mixed as described in Materials and Methods and aliquots were made.
One of these aliquots was immediately utilized in qPCR reactions while all others were stored
at -20°C. Aliquots were then thawed either 1 day, 7 days, 1 month or 2 months later and qPCR
reactions were performed. S3 Table shows that all cryopreserved aliquots had a similar high ef-
ficiency (91.6%) as that of the freshly prepared reaction mixture. Reaction mixtures kept at
-20°C for up to a month for lytA, or two months for those mixtures targeting serotype 9AV or
9LN, detected 2.1 genome equivalent per reaction (S3 Table). The lytA reaction mixture was
able to detect 21.4 genome equivalent per reaction when cryopreserved for 2 months. Our re-
sults indicate that ready-to-use reaction mixtures can be prepared and stored for up to 1
month at -20°C with no loss of efficiency or limit of detection.
Detection and quantification of bacterial load of pneumococcal
serotypes in nasopharyngeal samples
To date, real-time PCR studies for detecting pneumococcal serotypes have focused on no more
than 23 different serotypes/serogroups in NP samples. Having validated and optimized 53 sin-
gle-plex qPCR reactions, we investigated the presence, and quantified the bacterial load, of
these serotypes/serogroups in NP samples. For these proof-of-concept studies, we selected NP
samples that had been previously screened for the presence of S. pneumoniae by the lytA qPCR
assay. As we were primarily interested in detection of multiple serotypes/serogroups, these NP
samples were selected to contain106 CFU/ml of S. pneumoniae, as we thought high S. pneu-
moniae loads might be indicative of colonization by multiple serotypes.
Single-Plex Assays for Pneumococcal Serotyping
PLOS ONE | DOI:10.1371/journal.pone.0121064 March 23, 2015 8 / 19
In contrast to what we hypothesized, our studies demonstrated colonization by a single S.
pneumoniae strain in 50% (N = 15) of these NP samples (not shown). The bacterial load of the
identified serotypes (106 CFU/ml) correlated with the load of S. pneumoniae obtained by the
lytA assay, further supporting these samples contain only one serotype (Fig. 1, black dots).
Strains belonging to serotypes 6D, and 19A and serogroup 15, were detected in two different
samples, whereas 6A, 6B, 19BF, 19“F”, 23F, 9LN, 13, 21, and 33AF were detected in only one
(Fig. 1). Serotype 13 and serotype 21 in this study were only detected in NPs with single
serotype colonization.
Multiple colonization (2 serotypes) was observed in 50% of the NP samples tested. Of
these, 33% carried 2 different serotypes, 7% contained 3 serotypes, 3% carried 4 serotypes, and
5 serotypes were detected in 7% of samples (not shown). NP samples with multiple coloniza-
tion always contained a strain that contributed more than 50% of the bacterial load (Table 2).
For example, NP specimen 29 contained in proportion 99.94% (1.44x107 CFU/ml; Cq 26.84) of
Fig 1. Distribution and densities of S. pneumoniae serotypes in single or multiple colonized nasopharyngeal (NP) samples. Density (CFU/ml as
determined by lytA qPCR) of the specified serotype is presented on the x axis. Symbols for each serotype indicates the number of times they were detected
as a unique serotype (•) or in samples with multiple colonization (^).
doi:10.1371/journal.pone.0121064.g001
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serotype 16F vs only 0.06% (8.93x103 CFU/ml; Cq 38.0) of serotype 33A/F (Table 2). A total of
11 different serotypes/serogroups were carried as proportionally dominant (>50% of the total
load). Eleven serotypes/serogroups were only carried at a low proportion (<50%) including
vaccine serotype 6B and emergent 6C. Some strains, such as those of serogroup 15, contributed
in proportion with as low as 0.02% (4.7x103 CFU/ml; Cq 38.7) of total pneumococcal load and
as high as 99.3% (2.2x107 CFU/ml; Cq 25.8) while these strains were also detected in samples
containing, 2, 3, 4 or 5 different serotypes (Table 2 and S4 Table). The highest bacterial load of
a given serotype/serogroup in NP samples containing multiple serotypes/serogroups was
2.1x108 CFU/ml of serotype 9 in a NP sample containing 2 strains whereas the lowest load de-
tected was 3.15x103 CFU/ml of serotype 16F (Cq 39.4) in a NP sample containing 5 different
serotypes/serogroups (S4 Table).
Comparison of serotyping results by culture and by qPCR, including
correlation between the dominant serotype identified by each method
Serotyping results obtained by qPCR were compared with results from previous analysis by
culture and traditional serotyping of up to 120 colonies using a combination of latex agglutina-
tion and the Quellung reaction [28], with the numerically dominant serotypes obtained by cul-
ture compared with those proportionally dominant by qPCR (Table 3). In samples containing
a single serotype/serogroup (n = 14), there was a perfect correlation between the dominant se-
rotype obtained by culture to that obtained by qPCR, except for one culture-negative sample
(NP4), in which serotype 6D was identified by qPCR. In samples with multiple colonization
(n = 15), the dominant serotype obtained by culture correlated with the serotype/serogroup
present in highest proportion as quantified by qPCR only in*73% (n = 11) samples (Table 3).
In the remaining*33% (n = 4), the dominant serotype isolated by culture did not correlate
with the proportionally dominant type by qPCR but could be detected in most samples at a
lower proportion. In the samples with multiple colonization, a total of 40 serotypes were identi-
fied by qPCR, of which 23 (57.5%) were also identified by culture. There were three serotypes
which were identified by culture and not qPCR: serotype 3 in NP23, serotype 11A in NP11 (al-
though the closely related 11F was detected by qPCR, suggesting a possible genetic variant),
and serotype 17F in NP6 (not tested by qPCR).
Amolecular approach, S6-q(PCR)2, to identify serogroup 6 strains
directly in NP samples
Some qPCR assays are unable to differentiate among closely-related specific serotypes, such as
those within serogroup 6. To begin exploring alternative approaches, we designed a molecular
procedure that allowed us to individually type serogroup 6 strains directly from NP swabs. As
this procedure includes a series of qPCR and PCR reactions targeting serogroup 6, it was
named S6-q(PCR)2. This series of reactions will type individual serotypes belonging to ser-
ogroup 6 by exclusion while obtaining the bacterial density of each serotype. In a first step, a
qPCR reaction detects serogroup 6 (i.e., 6A, 6B, 6C, and 6D), and a second reaction specifically
targets serotypes 6C and 6D. Our qPCR studies thus revealed that 8 out of 30 NP samples con-
tained serogroup 6 strains, with 4 of them giving a positive reaction for 6C and 6D [Fig. 2 panel
(I)]. These results indicate that NPs 4, 6, 9, and 13 carry either 6C or 6D and, by exclusion, the
other 4 NP samples contain 6A or 6B (e.g., NPs 3, 14, 20, and 25).
Having separated NPs into those containing 6A or 6B or those with 6C or 6D, to identify indi-
vidual serotypes we utilized two different conventional PCR reactions. These reactions target nu-
cleotide polymorphisms within the wciP gene, thereby detecting the presence of 6A and 6C or 6B
and 6D [37, 38]. As we have reported that DNA from NP samples containing104 CFU/ml of
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S. pneumoniae load generates an amplicon by conventional PCR [31], extracted DNA from NP
samples positive for serogroup 6 by qPCR was used as template. As hypothesized, serotype
6-specific PCR products were amplified from all NPs (Fig. 2 panels II, III, and IV). The first PCR
reaction identified three NPs with serotype 6A or 6C strains, and therefore NP sample 20, which
had been typed by qPCR as carrying 6A or 6B, contains serotype 6A. Utilizing the same algo-
rithm, NPs 6 and 9 that had been typed by qPCR to have 6C or 6D, carried serotype 6C strains
[Fig. 2, panel (II)]. As expected, the second PCR reaction that targets 6B and 6D was negative for
these three NPs. In this second reaction, the other five NPs were positive indicating that NPs 3,
14, and 25 contained serotype 6B while NPs 4 and 13 carried a serotype 6D strain [Fig. 2, panel
(II) and (III)]. The last reaction [Fig. 2, panel (IV)], identifies serotypes 6C or 6D and served as
an extra control for our studies. Fig. 3 shows a summary of our molecular algorithms for the
identification and quantification of serotype 6 strains utilizing S6-q(PCR)2. This molecular
Table 3. Agreement between serotypes obtained by culture and those obtained by qPCR.
Serotypes detected by culture Serotypes detected by qPCR
NP Dominant serotype Other serotypes* Dominant serotype Other serotypes
9 6C 10A, NT 14 10A, 6C, 18BC, 10B
19 19B 19BF 46, 12AF, 15, 16F
6 15A 6C, 17F 15 6C, 19“F”,10B
11 11A 15B/C, 23F 23F 11F, 15
5 19A 9L, 14 19A 9LN, 14
7 9L 9LN 15
28 15A 15 3
10 19F NT 19“F” 5
14 7B 7B/40 6B
29 16F 16F 33AF
18 35A 8 8 35AC/42
16 25A/38 38 35AC/42
3 23F 23F 6B
23 3 23F, 11A 23F 11AD
8 19F 15C 19“F” 15
4 none 6D
1 21 21
26 9L 9LN
12 15B 15
21 19A 19A
24 19A 19A
25 6B 6B
22 23F 23F
20 6A 6A
30 13 13
2 19F 19BF
27 33A 33AF
15 15B 15
13 6D 6D
17 19F 19“F”
* NT = non-typeable pneumococci
doi:10.1371/journal.pone.0121064.t003
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approach proved to be useful to identify, and quantify serogroup 6 strains directly in DNA puri-
fied fromNP specimens.
Discussion
In this study we have optimized and validated a total of 53 qPCR assays, including 27 newly de-
veloped assays, for the detection and quantification of the bacterial load for pneumococcal se-
rotypes/serogroups. This represents an important contribution to the currently available 12
[39], 16 [40] or 21 [27] multiplex qPCR reactions for S. pneumoniae serotypes/serogroups.
These new qPCR assays can be utilized to expand currently available multiplex assays. Multi-
plex reactions for most pneumococcal serotypes can be first utilized to identify serotypes/ser-
ogroups in field samples. Once the serotype(s) is identified, then single-plex qPCR reactions
optimized in this study will allow us to obtain the specific bacterial load.
Using these new qPCR assays (Table 1), our proof-of-concept studies identified multiple se-
rotypes/serogroups in a number of samples examined, and the bacterial load was determined.
Similar studies have identified more than five pneumococcal serotypes using real-time PCR or
microarrays in specimens collected from Dutch or Thai children, respectively [19, 41]. Our
studies, however, were limited to a small number of samples. Future studies with a larger
Fig 2. Quantification and subtyping, by exclusion, of serotypes 6A, 6B, 6C, and 6D by S6-q(PCR)2. DNA from NP samples was utilized as template in
qPCR and PCR reactions. (I) The first set of qPCR reactions quantified serogroup 6, including serotype 6A, 6B, 6C and 6D (top panel), whereas the second
specifically quantified serotypes 6C and 6D (bottom panel). Serotype 6A and 6B or serotype 6C or 6D are differentiated by one single nucleotide
polymorphisms (SNPs) in thewciP gene. To type individual serotypes, PCR reactions were performed targeting subtype SNPs within thewciP gene to
identify (II) serotypes 6A and 6C or (III) serotypes 6B and 6D strain. A PCR targeting (IV) serotypes 6C and 6D specifically by amplifying thewciNβ gene was
performed as an additional control.
doi:10.1371/journal.pone.0121064.g002
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number of specimens are warranted. While identifying serotypes by using multiplexed reac-
tions may be an appropriate approach for field studies, having single-plex reactions able to
quantify the bacterial density may also be required as efforts are being made to utilize nasopha-
ryngeal density to diagnose pneumococcal pneumonia [42]. Density may also be an important
measure of vaccine impact. Carriage density may predict likelihood of transmission and impact
herd immunity. For example, in HIV-infected adults hospitalized with radiographically con-
firmed community acquired pneumonia (CAP), a lytA qPCR density8000 CFU/ml had a
sensitivity of 82.2% and a specificity of 92.0% for distinguishing pneumococcal CAP from
asymptomatic colonization [42].
Most quantitative assays for pneumococcal serotypes developed here (N = 21) detected
*2.1 genome equivalent per reaction whereas for the remaining 6 assays the limit of detection
was*21.4 genome equivalent per reaction. This represents an improved limit of detection or
similar limit of detection, respectively, to that reported earlier [27, 39, 40].
Quantitative assays reported in this study were validated in reactions containing a final vol-
ume of 10 μl, in contrast to all other published reactions that utilize 25 μl of final reaction
Fig 3. Algorithm for the identification and quantification of serotype 6 types directly from NP samples by S6-q(PCR)2. DNA purified from NP samples
is utilized as template in qPCR and PCR reactions. Arrows indicate reactions to be performed, qPCR in dark gray boxes or PCR in light gray boxes, and
continuous lines indicate reaction results. The final serotype obtained is indicated in the black boxes.
doi:10.1371/journal.pone.0121064.g003
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volume [22, 27, 39, 40]. Reducing the reaction volume also allowed us to reduce the volume of
DNA template without compromising the limit of detection. For comparison purposes, other
studies have utilized 2 [39], 2.5 [40], 5 [27] or 6 [22] μl of DNA template whereas our validated
protocol requires only 1 μl per reaction. Reducing the amount of DNA template might allow
the use of these reactions in retrospective studies where the volume left from stored biological
material is an important issue.
This report is to the best of our knowledge the first to demonstrate that 2-years cryopre-
served, FAM-labeled, qPCR probes yielded a similar reaction efficiency as that of freshly pre-
pared probes. This information is important for planning and budgetary purposes when
conducting longitudinal studies as sets of primers and probes do not need to be re-stocked
within 2 years. Moreover, the current availability of real-time systems almost everywhere in the
world but the lack of appropriate laboratory facilities to prepare qPCR reaction mixtures avoid-
ing contamination (i.e., a dedicated room with laminar flow hood for mixing components of
the qPCR assays, etc.) motivated us to test the stability at -20°C of qPCR reaction mixtures.
There was no loss of limit of detection in reaction mixtures cryopreserved for at least 1 month,
thereby studies involving different countries or different locations within the same country
may benefit by preparing the mixtures in central facilities, and then distributing ready-to-use
real-time reagents. Additionally, molecular testing with the exact same reagent may generate
more consistent results throughout study sites.
As mentioned earlier, the aim of this study was not to conduct an epidemiological investiga-
tion, but to make the primers and probe sequences and reaction protocols available while test-
ing NP samples as a proof-of-concept of what the new assays could add to the field. The
density of the total pneumococcal load (Table 2) did not appear to indicate the presence of sin-
gle or multiple colonization, since four samples containing only one serotype (NPs 1, 4, 12 and
26) had loads higher than one of the two samples containing 5 different serotypes (NP 19,
2.4x107 CFU/ml). As expected, in samples where only one serotype was found, the serotype re-
sult by qPCR correlated to that obtained by culture. In contrast, in samples containing multiple
serotypes, the dominant serotype by culture did not always match that present in the highest
proportion by qPCR, and many serotypes detected by qPCR were not found using culture-
based methods. These discrepancies may be due to a variety of reasons, including loss of viabili-
ty following freeze-thaw, increased limit of detection of the qPCR for detecting serotypes pres-
ent in low numbers, or subtle differences between the aliquots tested.
Atypical serotype 19F strains (referred here as 19“F”) were detected and quantified using a
new qPCR reaction. This 19“F” variant was originally reported by Pimenta, et al. (2009) [35].
Authors determined that 19“F” encoded a wzy gene (target for molecular typing) with*88%
identity to known 19A cps loci. Similar strains have been recently isolated in Brazil [36]. Our
studies obtained in culture pneumococci that were Quellung typed as 19F (Table 3) but that
our qPCR assays targeting serotypes 19F, or 19A, did not detect. A new qPCR reaction de-
signed based on the sequence of the wzy gene encoded by those isolates allowed us the identifi-
cation of 19“F” strains in four nasopharyngeal specimens. This reaction should be helpful for
surveillance studies using qPCR platforms for molecular serotyping.
Although qPCR assays were tested against a panel of non-pneumococcal streptococci with
no cross-reactivity observed, further confirmation of the specificity of these assays is warranted.
For example, Carvalho et al (2013) detected positivity for reactions amplifying some pneumo-
coccal serotypes (i.e., 12F/12A/44/46 and 33F/33A/37) in lytA negative nasopharyngeal/oro-
pharyngeal samples and from a S. oralis strain isolated from those NPs [43]. Our proof-of-
concept studies with NP swabs, presented in Table 3, were conducted on lytA positive speci-
mens. Whereas we obtained positivity in a lytA-positive NP specimen for our reaction amplify-
ing serotypes 12AF, from which the strain was not recovered in culture (NP#19); moreover,
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our reaction targeting 33AF sequences yielded a positive result and a pneumococcal strain se-
rotype 33A was isolated from the NP specimen #27 (Table 3).
Another important contribution within this work is the procedure that we have called S6-q
(PCR)2 for identifying and quantifying serogroup 6 strains. There is currently no available real-
time assays to identify and quantify individual serogroup 6 serotypes directly fromNP swabs.
Available PCR assays require the isolation of the serotype by culture and use purified DNA as
template [37, 38]. Detecting specific serotypes within serogroup 6 strains is particularly impor-
tant as serotypes 6A and 6B are vaccine types with a high prevalence worldwide in PD [9, 11].
Furthermore, 6C strains are increasing in prevalence post PCV introduction [44–46], while 6D
strains have recently emerged as a new serotype [37, 47, 48]. Strains carrying polymorphisms
within the wzy gene belonging to a variant called “6E” have been isolated in Korea; whether these
strains exist in other countries is unknown [49]. We combined two technologies, qPCR and con-
ventional PCR, to successfully identify and quantify individual serogroup 6 types in 8 different
NP samples. S6-q(PCR)2 required two qPCR reactions. The first reaction identified samples con-
taining serogroup 6 (6A, 6B, 6C or 6D) and obtained the density. A second qPCR reaction sepa-
rated samples with serotypes 6C, 6D or by exclusion, if the reaction was negative, serotype 6A or
6B. Finally, conventional PCR dissected the presence of specific types (Fig. 3). S6-q(PCR)2 identi-
fied vaccine type 6B and 6D in NPs where they had not been identified by culture (Table 3). In-
terestingly, the bacterial load of 6B or 6C strains in NP colonized by multiple serotypes was
proportionally low in comparison with the dominant serotype. If this is happening in PCV-
vaccinated populations, then examination of serotypes by culture-based methods could under-
report these important serotypes. A limitation of S6-q(PCR)2 is that the PCR component of the
scheme requires a bacterial density of*1x104 CFU/ml to generate a PCR amplicon.
The introduction of pneumococcal conjugate vaccines more than 10 years ago have consid-
erably reduced the burden of pneumococcal diseases in countries were children have been vac-
cinated. In contrast, NP carriage of the pneumococcus have been maintained at similar rates
since serotypes not included in the vaccine have now gained access to, or increased in density
in the nasopharynx. The future of epidemiological and clinical studies to evaluate vaccination
efficacy may require both highly sensitive and quantitative assays.
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